Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Watch
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Kelvin P. Lee, MD

Advertisement

Articles by Kelvin P. Lee, MD

Kelvin P. Lee, MD

Dr. Lee on the Importance of Collaboration in Precision Medicine

ByKelvin P. Lee, MD
May 23rd 2022

Kelvin P. Lee, MD, discusses the importance of collaboration in precision medicine.

Kelvin P. Lee, MD

Dr. Lee on the Importance of Sequencing in Precision Medicine

ByKelvin P. Lee, MD
April 27th 2022

Kelvin P. Lee, MD, discusses the importance of sequencing in precision medicine.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on OncLive

    1

    ASCO Guideline Update Broadens First-Line Treatment Options for HER2+ Gastroesophageal Cancer

    2

    ASCO Issues First Guideline on ctDNA Testing in Solid Tumors and Lymphoma

    3

    Dr Wainberg on INCB161734 Activity in Refractory Pancreatic Cancer

    4

    European Commission Approves Teclistamab Plus Daratumumab for R/R Myeloma

    5

    CAR T-Cell Therapy Continues to Make Its Case in Early Relapsed Myeloma

    • Advertise
    • About OncLive
    • Editorial Board
    • MJH Life Sciences brands
    • Contact Us
    • Privacy
    • Terms & Conditions
    • Do Not Sell My Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    Brand Logo
    Download on Apple
    Download on Google Play

    © 2026 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us